Loading...
This week, NEJM Journal Watch has brought you coverage of study findings presented at this year's Annual Scientific Sessions of the American College of Cardiology and published simultaneously in peer-reviewed journals. Here is a compilation of our coverage, listed by the titles of meeting presentations, with the articles' first authors in parentheses. (Your NEJM Journal Watch subscription is required.)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (Heidenreich PA)
Antihypertensive Therapy for Mild Chronic Hypertension Improves Pregnancy Outcomes: A Pragmatic Multicenter RCT (Tita A)
SODIUM-HF: Study of Dietary Intervention under 100 Mmol in Heart Failure (Ezekowitz JA)
Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in Angina and Nonobstructive Coronary Arteries: Results of the EDIT-CMD Randomized Clinical Trial (Jansen TPJ)
Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients with Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial (PACMAN-AMI) (Räber L)
Association of Transthyretin VAL122ILE Variant with Incident Heart Failure and Mortality among Black Americans (Parcha V)
Catheter Ablation of Ventricular Tachycardia after the First Implantable Cardioverter Shock: Results from the PARTITA Trial (Della Bella P)
Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospitalized for Acute Heart Failure — Results from the EMPULSE Trial (Kosiborod MN)
Efficacy and Safety of Tranexamic Acid in Patients Undergoing Noncardiac Surgery: The Poise-3 Trial (Devereaux PJ)
Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events (Jacobs DR Jr)
Be on the lookout for more of our ACC 2022 coverage in the coming days.